Tag: iab endocrine and metabolic diseases
-
Sanofi becomes the latest drugmaker to announce insulin price cuts capped at $35 for the privately insured
CNN — Sanofi is slashing the list price of Lantus, the most commonly prescribed insulin in the U.S., by 78% and setting a $35 monthly limit for those with private insurance, the company announced Thursday. The change takes effect on January 1. The move follows similar moves from Eli Lilly and Novo Nordisk this month. […]